The updated landscape of tumor microenvironment and drug repurposing

MZ Jin, WL Jin - Signal transduction and targeted therapy, 2020 - nature.com
Accumulating evidence shows that cellular and acellular components in tumor
microenvironment (TME) can reprogram tumor initiation, growth, invasion, metastasis, and …

Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities

B Huang, B Song, C Xu - Nature metabolism, 2020 - nature.com
Cholesterol metabolism produces essential membrane components as well as metabolites
with a variety of biological functions. In the tumour microenvironment, cell-intrinsic and cell …

Statin drugs to reduce breast cancer recurrence and mortality

CH Beckwitt, A Brufsky, ZN Oltvai, A Wells - Breast Cancer Research, 2018 - Springer
Epidemiologic studies have, variably, shown the concomitant use of statin drugs to be
beneficial to cancer outcomes. Statin drugs have been FDA approved for three decades for …

Lipid metabolism in oncology: why it matters, how to research, and how to treat

Y Matsushita, H Nakagawa, K Koike - Cancers, 2021 - mdpi.com
Simple Summary Metabolic reprogramming is gaining attentions as a hallmark of cancers.
However, lipid metabolism has been difficult to analyze due to technical problems. In recent …

Statin associated lower cancer risk and related mortality in patients with heart failure

QW Ren, SY Yu, THK Teng, X Li… - European heart …, 2021 - academic.oup.com
Aims Patients with heart failure (HF) have an increased risk of incident cancer. Data relating
to the association of statin use with cancer risk and cancer-related mortality among patients …

Dysregulation of cholesterol metabolism in cancer progression

X Liu, M Lv, W Zhang, Q Zhan - Oncogene, 2023 - nature.com
Cholesterol homeostasis has been implicated in the regulation of cellular and body
metabolism. Hence, deregulated cholesterol homeostasis leads to the development of many …

Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance

M Tajaldini, A Poorkhani, T Amiriani, A Amiriani… - European Journal of …, 2023 - Elsevier
The use of repurposing drugs that may have neoplastic and anticancer effects increases the
efficiency and decrease resistance to chemotherapy drugs through a biochemical and …

Lipid pathway deregulation in advanced prostate cancer

L Galbraith, HY Leung, I Ahmad - Pharmacological research, 2018 - Elsevier
The link between prostate cancer (PC) development and lipid metabolism is well
established, with AR intimately involved in a number of lipogenic processes involving …

Statins and prostate cancer—hype or hope? The epidemiological perspective

EL Craig, KH Stopsack, E Evergren, LZ Penn… - Prostate cancer and …, 2022 - nature.com
Background Men using cholesterol-lowering statin medications have been found to have
lower risks of both advanced and fatal prostate cancer in multiple registry-based studies and …

LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies

G Revilla, L Cedó, M Tondo, A Moral, JI Pérez… - Seminars in cancer …, 2021 - Elsevier
Cholesterol is essential for a variety of functions in endocrine-related cells, including
hormone and steroid production. We have reviewed the progress to date in research on the …